Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36726 - 36750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CD44	960	upregulated	entinostat results in increased expression of CD44 mRNA	11p13	A21037
Entinostat	Investigational	CD52	1043	upregulated	entinostat results in increased expression of CD52 mRNA	1p36.11	A21035
Entinostat	Investigational	CD58	965	upregulated	entinostat results in increased expression of CD58 mRNA	1p13.1	A21037
Entinostat	Investigational	CD70	970	upregulated	entinostat results in increased expression of CD70 mRNA	19p13.3	A21035
Entinostat	Investigational	CD74	972	upregulated	entinostat results in increased expression of CD74 mRNA	5q33.1	A21035
Entinostat	Investigational	CD83	9308	upregulated	entinostat results in increased expression of CD83 mRNA	6p23	A21035
Entinostat	Investigational	CD9	928	upregulated	entinostat results in increased expression of CD9 mRNA	12p13.31	A21037 A21035
Entinostat	Investigational	CD99L2	83692	downregulated	entinostat results in decreased expression of CD99L2 mRNA	Xq28	A21037
Entinostat	Investigational	CDA	978	upregulated	entinostat results in increased expression of CDA mRNA	1p36.12	A21037
Entinostat	Investigational	CDC14A	8556	downregulated	entinostat results in decreased expression of CDC14A mRNA	1p21.2	A21037
Entinostat	Investigational	CDC25A	993	downregulated	entinostat results in decreased expression of CDC25A mRNA	3p21.31	A21035
Entinostat	Investigational	CDC42EP5	148170	upregulated	entinostat results in increased expression of CDC42EP5 mRNA	19q13.42	A21037
Entinostat	Investigational	CDC42SE2	56990	downregulated	entinostat results in decreased expression of CDC42SE2 mRNA	5q31.1	A21035
Entinostat	Investigational	CDCA7L	55536	upregulated	entinostat results in increased expression of CDCA7L mRNA	7p15.3	A21037
Entinostat	Investigational	CDCP1	64866	upregulated	entinostat results in increased expression of CDCP1 mRNA	3p21.31	A21037
Entinostat	Investigational	CDH1	999	upregulated	entinostat results in increased expression of CDH1 mRNA	16q22.1	A21037
Entinostat	Investigational	CDH11	1009	downregulated	entinostat results in decreased expression of CDH11 mRNA	16q21	A21037
Entinostat	Investigational	CDH12	1010	downregulated	entinostat results in decreased expression of CDH12 mRNA	5p14.3	A21035
Entinostat	Investigational	CDH18	1016	upregulated	entinostat results in increased expression of CDH18 mRNA	5p14.3	A21037
Entinostat	Investigational	CDH2	1000	downregulated	entinostat results in decreased expression of CDH2 mRNA	18q12.1	A21037
Entinostat	Investigational	CDH3	1001	upregulated	entinostat results in increased expression of CDH3 mRNA	16q22.1	A21037
Entinostat	Investigational	CDH6	1004	downregulated	entinostat results in decreased expression of CDH6 mRNA	5p13.3	A21037
Entinostat	Investigational	CDH6	1004	upregulated	entinostat results in increased expression of CDH6 mRNA	5p13.3	A21035
Entinostat	Investigational	CDH8	1006	downregulated	entinostat results in decreased expression of CDH8 mRNA	16q21	A21037 A21035
Entinostat	Investigational	CDH9	1007	upregulated	entinostat results in increased expression of CDH9 mRNA	5p14.1	A21037

Displaying entries 36726 - 36750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability